SWK Holdings Corporation is a specialized investment firm focused on the life sciences sector, dedicated to generating high-risk-adjusted returns through innovative financing solutions aimed at transformative therapies. The issuance of its 9.00% Senior Notes due 2027 highlights SWK's proactive approach in funding high-potential healthcare advancements. With deep industry expertise and a strategic investment framework, the company seeks to create substantial value for institutional investors while adeptly navigating the complexities of the dynamic healthcare landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SWKHL and any ticker you trade — then tracks every position and per-strategy win rate.